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Edited by Christian GriesingerAbstract The potential application of lantibiotics as food-pre-
serving agents and more recently as antibiotics has strongly in-
creased the interest in these antibacterial peptides. Here, we
report the elucidation of the primary and three-dimensional
structures of the novel lantibiotic epilancin 15X from Staphylo-
coccus epidermidis using high-resolution nuclear magnetic reso-
nance spectroscopy and tandem mass spectrometry. The
molecule contains ten post-translationally modiﬁed amino acids,
three lanthionine ring structures and a hydroxy-propionyl N-ter-
minal moiety. The primary and tertiary structure and the distri-
bution of positive charges are closely similar to the previously
identiﬁed lantibiotic epilancin K7, most likely indicative of a
common mode of action.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Lantibiotics is the name for a group of bacterial peptides
with antibacterial action, which are ribosomally synthesized
as prepeptides and post-translationally modiﬁed to contain
the dehydrated amino acids a,b-didehydroalanine (Dha)Abbreviations: HMBC, heteronuclear multiple bond correlation;
HSQC, heteronuclear single-quantum correlation; MS, mass spec-
trometry; MS/MS, tandem mass spectrometry; NMR, nuclear mag-
netic resonance; NOESY, nuclear Overhauser enhancement
spectroscopy; TOCSY, total correlation spectroscopy; Dha, dehydro-
alanine; Dhb, dehydrobutyrine; MeLan, 3-methyllanthionine; Lan,
lanthionine; Hop, hydroxy-propionyl
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doi:10.1016/j.febslet.2005.01.083and a,b-didehydrobutyric acid (Dhb) as well as the thioether
bridges formed by lanthionine (Lan) and b-methyllanthio-
nine (MeLan) [1–3] (see also Fig. 1). Nisin, a member of
the lantibiotic family, has been commonly used as a food
preservative (known as E234) for its strong activity against
food pathogens [4]. Recently, the application of lantibiotics,
as antibiotic reagents, has moved a big step forwards as the
structure of nisin in complex with its natural target lipid II
revealed a possible common motif that may pave the way
to the design of novel antibiotics [5]. The potential applica-
tion of other lantibiotics as food preservatives or as antibiot-
ics has led so far to the discovery of over 40 diﬀerent
lantibiotics, produced by bacteria isolated from diﬀerent
sources.
Lantibiotics are sub-divided into type A and type B peptides.
Type A lantibiotics are ﬂexible, cationic and elongated pep-
tides which exert their function by pore formation in the bac-
terial membrane, whereas type B are generally more rigid
globular molecules that act by disruption of enzyme functions
such as peptidoglycan biosynthesis and phospholipase activity
[2].
The lantibiotic described in this paper is produced by Staph-
ylococcus epidermidis 15X154, a clinical strain isolated from a
wound infection. S. epidermidis is a Gram positive, katalase
positive and coagulase negative coccus and is a colonizer of
the human skin. However, it may cause serious infections in
immuno-compromised patients and in patients with indwelling
devices [6]. Thus far, four lantibiotic peptides produced by S.
epidermidis strains have been identiﬁed, namely pep5 [7], epi-
dermin [8], epicidin 280 [9] and epilancin K7 [10,11], all of
which are type A lantibiotics.
Structural characterization of novel lantibiotics remains a
challenge, primarily due to the problematic designation of
the thioether bridges [3]. Nuclear magnetic resonance
(NMR) spectroscopy is often employed to complement
DNA sequencing in order to obtain a deﬁnitive primary se-
quence. In this paper, we combined NMR spectroscopy and
nano-scale liquid chromatography/tandem mass spectrometry
(MS) to determine the primary sequence and molecular
structure of the newly isolated active peptide. The peptide
was found to highly resemble the previously identiﬁed epi-
lancin K7 [10,11] with 68% sequence identity, three nearly
identical lanthionine rings and a modiﬁed amino acid at
the N-terminus. This prompted us to name the new lantibi-
otic epilancin 15X.blished by Elsevier B.V. All rights reserved.
Fig. 1. The 1Ha–13Ca region of a natural abundance 1H–13C-HSQC spectrum of epilancin 15X. Peaks are labeled with the corresponding residue
number and identity. The inset shows the glycine region. The structure of the post-translational modiﬁed residues is shown in the right. The N-
terminus is a Hop group indicated as Hop.
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2.1. Isolation and puriﬁcation of the active peptide
1.5 liters of Mueller Hinton broth were inoculated with 100 ll of
overnight S. epidermidis 15X154 culture and incubated for 16 h at
37 C on a shaker. After centrifugation, the supernatant was ﬁlter ster-
ilized and puriﬁed on an A¨kta FPLC system (Amersham, Uppsala,
Sweden) by cation exchange chromatography (HiTrap SP XL), hydro-
phobic interaction chromatography (Source 15 PHE) and reverse
phase chromatography (Source 15 RPC, Amersham), essentially as de-
scribed previously [12]. Activity in the FPLC fractions was determined
as described previously [13], using Staphylococcus aureus strain 29213
as the indicator strain. The puriﬁed compound was stored at 4 C.
2.2. NMR spectroscopy
Two-dimensional homonuclear 1H total correlation spectroscopy
(TOCSY) and nuclear Overhauser enhancement spectroscopy
(NOESY) spectra were recorded on a Bruker DRX 750 MHz spec-
trometer at 305 and 283 K with 1.25 mg of epilancin 15X dissolved
in 500 ll of 90% H2O/10% D2O, 10 mM d3-sodium acetate at pH 4.
Mixing times were 100, 200 and 300 ms in the NOESY experiments
and 80 ms in the TOCSY experiments. Natural abundance 1H–13C het-
eronuclear single-quantum correlation (HSQC) and 1H–13C heteronu-
clear multiple bond correlation (HMBC) NMR spectra were acquired
on a Bruker Avance 600 MHz spectrometer equipped with a cryoprobe
system at 283 K with 3 mg epilancin 15X in 300 ll D2O using a Shi-
gemi tube. The 1H and 13C spectral widths were 10 ppm and 150 or
200 ppm, respectively. All spectra were processed using NMRPipe
[14] and analyzed using NMRView [15].
The assigned chemical shifts were deposited in BioMagResonBank
under Accession No. 6352.
2.3. Structure calculation and analysis
Structure calculations were performed with CNS [16] using the
ARIA setup and protocols [17]. Most peaks in the NOESY spectra
were unambiguously assigned, except for those that show spectraloverlap, which were assigned as ambiguous with a lower weighing
factor. The semi-automated NOE assignment with ARIA and addi-
tional parameters and topologies introduced to deﬁne Dha, Dhb,
MeLan and Lan were done as described previously [18]. The topol-
ogy for hydroxy-propionyl (Hop) was constructed based on alanine
with comparison of available databases. Three thioether bridges be-
tween residues 12 and 16 (ring A), 20 and 23 (ring B) and 22 and
25 (ring C) were introduced. A simulated annealing protocol was
performed using torsion angle dynamics as described before [18].
All 100 structures were subjected to explicit solvent reﬁnement
[19] and the 20 lowest-energy structures were kept for structural
analysis.
The structural coordinates were deposited in the Research Collabo-
ratory for Structural Bioinformatics (RCSB) Protein Data Bank
(PDB) under Accession Code 1W9N.
2.4. Mass spectrometry
Nano-scale liquid chromatography MS and tandem MS (MS/MS)
were performed on a 1100 series liquid chromatography system (Agi-
lent Technologies, Palo Alto, CA, USA) and a Q-Tof Ultima API hy-
brid quadrupole/time of ﬂight mass spectrometer (Waters corporation,
Milford, MA, USA) as described previously [20]. Samples were diluted
to 1 fmol/ll in 5% DMSO/5% formic acid and 10 ll were injected onto
a C18 trapping column. Analyte separation was performed on a C18
column using a linear gradient from 0% to 60% acetonitril + 0.1 M
acetic acid (both columns manufactured by Nano-separations, Nieuw-
koop, The Netherlands). Data were analyzed using the MassLynx 3.4
software.2.5. Peptide digestion
The peptide was hydrolyzed with modiﬁed trypsin according to
the procedure provided by the supplier (Boehringer Mannheim,
Germany). Approximately 100 pmol of peptide was incubated
with 20 pmol enzyme in a buﬀer solution (100 ll) for 4 h at
37 C. Digestion was terminated by acidiﬁcation with 1 ll of acetic
acid.
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3.1. Isolation and puriﬁcation
Pure epilancin 15X was obtained in a three-step liquid chro-
matography setup as often described for lantibiotics [9,21]. The
yield was typically 0.5 mg peptide/l culture. Antibiotic activity
remained stable during the puriﬁcation process and partly
puriﬁed peptide solutions could be stored for several weeksFig. 2. Analysis of epilancin 15X by MS. (A) Mass spectrum of epilancin
Chromatogram of epilancin 15X and (C) of the peptide digest fragments. A
fragments 1–10 (489.72+) and (E) of 18–31 (723.42+). Fragment ions are marat 4 C without signiﬁcant loss of activity. Epilancin 15X
was found to be active against a range of gram positive mi-
cro-organisms, such as staphylococci, enterococci and strepto-
cocci (data not shown).
3.2. Spin system analysis & sequence determination by NMR
The number and nature of residues of the peptide was deter-
mined using the 2D TOCSY and NOESY spectra recorded at15X. The [M + 6H]6+ ion (m/z ratio 529.729) is most abundant. (B)
fter digestion, ﬁve new peaks can be retrieved. (D) MS/MS spectra of
ked.
1920 M.B. Ekkelenkamp et al. / FEBS Letters 579 (2005) 1917–1922283 K. No signs of spin diﬀusion were observed in the 300 ms
NOESY spectrum so it was used for the structure calculation.
For initial identiﬁcation of each spin system, chemical shifts
were compared with random coil values [22]. A similar ap-
proach was applied for the modiﬁed amino acids by compari-
son with other lantibiotics [5,10,23,24]. Sequential assignment
was achieved using standard NOE connectivity-based protocol
[25]. Spectral overlaps were resolved by inspection of either
homonuclear NMR spectra at 305 K or by the 13C heteronu-
clear spectra. All residues could be unambiguously identiﬁed
and sequentially assigned in this way. The results were then
conﬁrmed by the 1H–13C HMBC experiment. In addition,
the combined use of the 1H–13C HSQC and 1H–13C HMBC
spectra enabled complete 13C chemical shift assignment of
the backbone Ca and side chain carbon atoms, and 87% of
the carbonyl atoms. Fig. 1 shows the assigned 1Ha–13Ca re-
gion of the 1H–13C HSQC.
The observation of the Ala2 amide proton (which was ﬁrst
believed to be the N-terminal residue) led to the idea of an
additional residue located prior to it. Comparison with Pep5,
epicidin 280 and epilancin K7 [26] and close inspection of all
NMR spectra in conjunction with the molecular weight ob-
tained from MS (see the following section) allowed us to
unambiguously assign the N-terminus to Hop. Analysis of
the NOE connectivities between the residue pairs of the lanthi-
onine rings allowed for the localization of the thioether
bridges.
The combined analysis of all NMR data established the pri-
mary structure of the active peptide with a calculated mass of
3173 Da: a total number of 31 residues, including 10 modiﬁed
amino acids, three lanthionine rings (denoted as A, B and C in
Fig. 3) and Hop at the N-terminus.
3.3. Analysis by MS
In order to verify the sequence obtained by NMR, mass
spectra of digested and undigested peptide samples were ana-
lyzed by MS. The mass spectrum of the undigested peptide
yielded an envelope of multiple charges ranging from 3 to 7
charges, the [M + 6H]6+ ions with a m/z of 529.7 being the
most abundant (Fig. 2A). A molecular weight of 3172.75 Da
was calculated, which is in agreement with the mass deter-
mined from the NMR-derived sequence.
In the analysis of the tryptic digest, ﬁve major fragments
were detected (Fig. 2B and C). These ions were selected for
MS/MS analysis (Fig. 2D and E) and were found to corre-Fig. 3. Primary structure of epilancin 15X compared to that of epilancin K
diﬀerent between the two lantibiotics are shaded grey. The positively charg
detected by MS are indicated by arrows.spond to residues 18–31, 1–5, 18–30, 1–10 and 18–29, respec-
tively. No digestion fragment corresponding with residues
11–17 could be identiﬁed. In the MS/MS spectrum of the
1–5 digest fragment, a- and b-ions were accompanied by ions
at 14 Da lower m/z value, which can be explained by the loss
of a CH2 group by the Hop moiety. As observed for other
lantibiotics [27,28], little cleavage occurred in the part of
the molecule containing two MeLan rings (between Abu20
and Ala25). Ion masses of 288.1 and 401.2 were found in
the spectra of all three digest fragments 18–29, 18–30 and
18–31 corresponding to the b3 and b4-ions formed by cleav-
age between Abu20 and Leu21, and between Leu21 and
Abu22, respectively. The mass diﬀerence of 83 Da between
the b2 (205.1) and b3-ion suggests loss of a hydrogen atom
and formation of Dhb from Abu after cleavage of the thioe-
ther bridge.
The cleavage sites retrieved by MS/MS are indicated in Fig.
3. A total of 21 out of 30 expected cleavage sites (70%) could
be conﬁrmed for epilancin 15X.
3.4. The 3D solution structure of epilancin 15X and comparison
to epilancin K7
The solution structure of epilancin 15X was determined
based on the NOE-derived distance restraints (Fig. 4 and Ta-
ble 1). Like many type A lantibiotics, it exhibits no conven-
tional secondary structure but well-deﬁned local ring
structures.
The temperature dependency of amide proton chemical
shifts (temperature coeﬃcient) provides information on the
involvement in hydrogen bond formation or sequestering
from the solvent and has been used in studies of other lan-
tibiotics [11,29]. The temperature coeﬃcients of individual
amide protons were measured (see Fig. 5) and compared
with those measured for epilancin K7 [11]. Generally, in
the regions of the ring structures, the lower temperature
coeﬃcients correlate with the lower surface accessibility of
the amide protons that was calculated from the ensemble
of 20 structures (data not shown). The sequential proﬁles
of the temperature coeﬃcients of the two homologous lanti-
biotics are very similar, indicating that epilancin 15X resem-
bles epilancin K7 also in 3D structure. Both molecules are
also highly positively charged (about 20% of the total num-
ber of amino acids) and the distribution of these charges are
almost identical except for the missing charge at the C-termi-
nus in epilancin K7 (see Figs. 3 and 4B). The homology7. Lanthionine rings A, B and C are indicated. The residues that are
ed residues are indicated by a plus sign. The cleavage sites that were
Fig. 4. The three-dimensional solution structure of epilancin 15X. (A)
Distribution of NOEs along the sequence divided into intra-residual
(white bars), sequential (hashed bars) and medium range NOEs (black
bars). Note that most medium-range NOEs were identiﬁed for residues
in rings B and C. (B) A combined ribbon/surface presentation of the
lowest-energy structure. The side chains of the positively charged
residues are shown in stick representation with the corresponding
residue numbers. The sulfur atoms in the three rings A, B and C are
shown in spheres. The ﬁgure was generated using MolMol [33]. (C)
The main-chain RMS displacements from the mean structure of the
ensemble of 20 lowest-energy structures showing that the structure is
mostly well-deﬁned for rings B and C, in agreement with the larger
number of medium-range NOEs observed in this region (panel A). The
three ring-systems A, B and C are indicated at the top of panels (A)
and (C).
Fig. 5. NMR-derived structural data for epilancin 15X and epilancin
K7. The temperature-coeﬃcients (Dd/DT) of epilancin 15X were
derived from TOCSY experiments at 283 and 305 K, and are shown
by dark-grey bars. The temperature-coeﬃcients of epilancin K7 [11]
are shown by white bars. Note the typical up-down pattern for the
residues in rings B and C in both peptides. The three ring-systems A, B
and C are indicated at the top of the ﬁgure.
Table 1
Structural statistics for the ensemble of twenty lowest-energy water-
reﬁned structures of epilancin 15X
Distance restraintsa
Intraresidue (i  j = 0) 209
Sequential (ji  jj = 1) 92
Medium range (2 6 ji  jj 6 4) 30
All 331
RMSD from idealized covalent geometry
Bonds (A˚) 0.0034 ± 0.00019
Angles () 0.58 ± 0.03
Impropers () 1.27 ± 0.15
CNS energies (kcal/mol)
Etotal 806 ± 37
Evdw 170 ± 5
Eelec 886 ± 36
Backbone (N,Ca and C 0) pair wise RMSD (A˚)b
All residues 7.63 ± 2.14
Residues 20–25 (rings B + C) 0.61 ± 0.34
aDistance restraint statistics reported for unique, unambiguous as-
signed NOEs. No NOE distance restraint was violated by more than
0.3 A˚ in any of the structures.
bCoordinate precision is given as the average pairwise Cartesian
coordinate root mean square deviations over the ensemble.
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may, as is the case for nisin A and nisin Z [30,31], be
natural variants.3.5. Concluding remarks
Because of the presence of post-translationally modiﬁed
amino acids, a reliable determination of lantibiotic amino acid
sequence and secondary structure depends on a combination
of techniques, usually DNA sequencing combined with
NMR spectroscopy. Initial diﬃculties with DNA sequencing,
which are not uncommon with lantibiotics, prompted us to
use MS, which was especially helpful in the identiﬁcation of
the N-terminal Hop. The molecular mass as measured by
1922 M.B. Ekkelenkamp et al. / FEBS Letters 579 (2005) 1917–1922MS matched the mass derived by NMR. In addition, MS/MS
was capable of conﬁrming several (stretches of) amino acid res-
idues. NMR was also successfully applied previously to deter-
mine the primary and tertiary structure of the nonadecapeptide
cinnamycin, a type B lantibiotic [32].
The high similarity in primary and tertiary structure as well
as in the distribution of positive charges, most likely reﬂects a
similar way in which epilancin K7 and the novel lantibiotic epi-
lancin 15X recognize their targets. These general properties
might be of great importance as they can provide the basis
for future design of antibiotic reagents.
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